Human immunodeficiency virus infection prevention: strategies for clinicians. 2003

Tanya Schreibman, and Gerald Friedland
AIDS Program, Yale School of Medicine, Yale University, Yale-New Haven Hospital, New Haven, Connecticut 06437, USA. schreibmans@hotmail.com

The complexity of the epidemic of human immunodeficiency virus (HIV) infection has made the creation of effective prevention programs an evolving and challenging task. Prevention of new HIV infections is an issue of increasing importance as the prevalence of HIV infection continues to increase. The integration of prevention and clinical care is recognized as a key element of future prevention activities. Prevention of HIV infection should extend beyond the traditional public health model to the clinical care site. The clinical care setting offers a unique opportunity to bring people with HIV disease into care and to establish relationships, thus creating a foundation for prevention-related activities. However, the expertise and energy that clinicians currently dedicate to diagnosis and treatment far exceeds that directed toward prevention. We review details about and the efficacies of specific prevention efforts of relevance in clinical practice, and we conclude with practical recommendations regarding the most simple and efficient ways of integrating both behavioral counseling and medical interventions as prevention tools into clinical practice.

UI MeSH Term Description Entries
D010820 Physicians Individuals licensed to practice medicine. Physician
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012309 Risk-Taking Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her. Risk Behavior,Behavior, Risk,Behaviors, Risk,Risk Behaviors,Risk Taking
D012749 Sexually Transmitted Diseases Diseases due to or propagated by sexual contact. Venereal Diseases,STDs,STIs,Sexually Transmitted Infections,Disease, Sexually Transmitted,Disease, Venereal,Diseases, Sexually Transmitted,Diseases, Venereal,Infection, Sexually Transmitted,Infections, Sexually Transmitted,STI,Sexually Transmitted Disease,Sexually Transmitted Infection,Transmitted Infection, Sexually,Transmitted Infections, Sexually,Venereal Disease
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018890 Chemoprevention The use of chemical compounds to prevent the development of a specific disease. Chemoprophylaxis
D019983 Guideline Adherence Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards. Institutional Adherence,Policy Compliance,Protocol Compliance,Adherence, Guideline,Adherence, Institutional,Compliance, Policy,Compliance, Protocol

Related Publications

Tanya Schreibman, and Gerald Friedland
March 1995, La Revue du praticien,
Tanya Schreibman, and Gerald Friedland
October 1995, Revista clinica espanola,
Tanya Schreibman, and Gerald Friedland
January 1991, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
Tanya Schreibman, and Gerald Friedland
November 2000, The American journal of medicine,
Tanya Schreibman, and Gerald Friedland
February 2020, Chinese medical journal,
Tanya Schreibman, and Gerald Friedland
September 1992, Obstetrics and gynecology,
Tanya Schreibman, and Gerald Friedland
July 2016, The Medical clinics of North America,
Tanya Schreibman, and Gerald Friedland
May 1991, Annals of the Academy of Medicine, Singapore,
Tanya Schreibman, and Gerald Friedland
January 2016, Oral surgery, oral medicine, oral pathology and oral radiology,
Copied contents to your clipboard!